Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jun;64(6):1912-3.
doi: 10.2337/db15-0188.

Therapeutic window of interleukin-2 for autoimmune diseases

Qizhi Tang  1
Affiliations
Comment

Therapeutic window of interleukin-2 for autoimmune diseases

Qizhi Tang. Diabetes. 2015 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
High responsiveness of Tregs to IL-2 and its biochemical basis. A: Schematic diagram illustrating the hierarchy of IL-2 responsiveness of human peripheral blood lymphocytes. B: High sensitivity of Tregs to IL-2 can be explained by higher expression of CD25 and PP2A-dependent enhancement of intracellular IL-2 signal transduction.
See this image and copyright information in PMC

Comment on

References

    1. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775–787 - PubMed
    1. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003;15:430–435 - PubMed
    1. Tang Q, Adams JY, Penaranda C, et al. . Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 2008;28:687–697 - PMC - PubMed
    1. Grinberg-Bleyer Y, Baeyens A, You S, et al. . IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med 2010;207:1871–1878 - PMC - PubMed
    1. Yu A, Snowhite I, Vendrame F, et al. . Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes 2015;64:2172–2183 - PubMed

Publication types